Safe AI by BiocommAI in cooperation with Normax

BiocommAI Inc. is a strategic sister company to NormaxAI. BiocommAI specializes Safe AI enabled digital health services for Patients and Doctors with regulatory compliant, extremely advanced, AI data centers with mathematically provable Safe AI for healthcare use cases including Oncology and Normax Educated Antigen Receptor Therapy (EARTh) GMP Process for Personalized Precision (n=1) mRNA Immunotherapy Vaccines for People Living with Cancer, in synergy with digital health apps and services for a better life with cancer.

U.S. Artificial Intelligence Safety Institute (AISI)

BiocommAI Inc. is an official member of the Artificial Intelligence Safety Institute Consortium (AISIC) by the U.S. National Institute of Standards and Technology (NIST). In support of efforts to create safe and trustworthy artificial intelligence (AI), NIST has established the U.S. Artificial Intelligence Safety Institute (USAISI). To support this Institute, NIST has created the U.S. AI Safety Institute Consortium (AISIC). The Consortium brings together more than 200 organizations to develop science-based and empirically backed guidelines and standards for AI measurement and policy, laying the foundation for AI safety across the world.